Effects of endurance training on the circadian rhythm of fibrinolysis in men and women

被引:22
作者
Chandler, WL
Schwartz, RS
Stratton, JR
Vitiello, MV
机构
[1] UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195
[2] UNIV WASHINGTON,DEPT PSYCHIAT & BEHAV SCI,SEATTLE,WA 98195
[3] VET ADM MED CTR,SEATTLE,WA 98108
[4] VET ADM MED CTR,CTR GERIATR RES EDUC & CLIN,SEATTLE,WA 98108
关键词
D O I
10.1097/00005768-199606000-00001
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
This randomized study compared the fibrinolytic circadian rhythm of healthy older men and older women (average age 66 +/- 5), before and after 6 months of endurance training versus stretching controls. Compared with men, women at baseline had similar rhythms for tissue plasminogen activator (t-PA) activity and plasminogen activator inhibitor 1 (PAI-1) activity, but lower levels of total t-PA antigen. In men (N = 16), endurance training increased VO2max 15% (P < 0.001), while decreasing PAI-1 activity 37% (P = 0.034) and total t-PA antigen 18% (P = 0.0003) between midnight and 6 a.m., but did not affect t-PA activity. In women (N = 9), endurance training increased VO2max 18% (P = 0.003), and increased t-PA activity 20% (P = 0.027) and total t-PA antigen 55% (P = 0.007) between 10 p.m. and 4 a.m., but had no effect on PAI-1 activity-After endurance training there were no significant differences in the fibrinolytic circadian rhythm of men versus women. Six months of nonaerobic stretching had no effect on VO2max or fibrinolysis in men (N = 11) or women (N = 8). This study indicates that potentially favorable changes occur in fibrinolytic factors after endurance training in older men and older women.
引用
收藏
页码:647 / 655
页数:9
相关论文
共 38 条
[1]   MAJOR CIRCADIAN FLUCTUATIONS IN FIBRINOLYTIC FACTORS AND POSSIBLE RELEVANCE TO TIME OF ONSET OF MYOCARDIAL-INFARCTION, SUDDEN CARDIAC DEATH AND STROKE [J].
ANDREOTTI, F ;
DAVIES, GJ ;
HACKETT, DR ;
KHAN, MI ;
DEBART, ACW ;
ABER, VR ;
MASERI, A ;
KLUFT, C .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (09) :635-637
[2]   DIURNAL-VARIATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ITS RAPID INHIBITOR (PAI-1) [J].
ANGLETON, P ;
CHANDLER, WL ;
SCHMER, G .
CIRCULATION, 1989, 79 (01) :101-106
[3]   A METAANALYSIS OF PHYSICAL-ACTIVITY IN THE PREVENTION OF CORONARY HEART-DISEASE [J].
BERLIN, JA ;
COLDITZ, GA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 132 (04) :612-628
[4]   INSULIN, CORTISOL AND CATECHOLAMINES DO NOT REGULATE CIRCADIAN VARIATIONS IN FIBRINOLYTIC-ACTIVITY [J].
CHANDLER, WL ;
MORNIN, D ;
WHITTEN, RO ;
ANGLETON, P ;
FARIN, FM ;
FRITSCHE, TR ;
VEITH, RC ;
STRATTON, JR .
THROMBOSIS RESEARCH, 1990, 58 (01) :1-12
[5]  
CHANDLER WL, 1989, J LAB CLIN MED, V113, P362
[6]  
CHANDLER WL, 1990, BLOOD, V76, P930
[7]  
CHANDLER WL, 1991, THROMB HAEMOSTASIS, V66, P321
[8]   INCREASED FIBRIN TURNOVER AND HIGH PAI-1 ACTIVITY AS PREDICTORS OF ISCHEMIC EVENTS IN ATHEROSCLEROTIC PATIENTS - A CASE-CONTROL STUDY [J].
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C ;
MUSSONI, L ;
DONATI, MB ;
CARDILLO, M ;
CATALANO, M ;
GABRIELLI, L ;
LOMBARDI, B ;
SPECCHIA, G ;
TAVAZZI, L ;
TREMOLI, E ;
POZZOLI, E ;
TURRI, M ;
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C ;
CARDILLO, M ;
TORRI, M ;
RAINISIO, M ;
GENTILE, G ;
MOREO, G ;
BIANCHI, O ;
LEONARDI, P ;
COLOMBI, M ;
CATALANO, M ;
GALIMBERTI, P ;
RUSSO, U ;
CRESSOTTI, A ;
CARZANIGA, G ;
NOBILI, S ;
NINNO, D ;
DONATI, MB ;
IACOVIELLO, L ;
DEGAETANO, G ;
GABRIELLI, L ;
MARTELLI, E ;
CORSI, G ;
LORENZI, G ;
LOMBARDI, B ;
CARRIERO, MR ;
COLOMBO, R ;
SPECCHIA, G ;
CIOFFI, P ;
SCIRE, A ;
TAVAZZI, L ;
GIANNUZZI, P ;
CORRA, U ;
TEMPORELLI, L ;
MORA, F .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (10) :1412-1417
[9]  
DECLERCK PJ, 1988, FIBRINOLYSIS S2, V2, P17
[10]   LOW-DOSE ASPIRIN DOES NOT PREVENT FIBRINOLYTIC RESPONSE TO VENOUS OCCLUSION [J].
DEGAETANO, G ;
CARRIERO, MR ;
CERLETTI, C ;
MUSSONI, L .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (18) :3147-3150